Seeking Alpha

Jason Napodano, CFA

I am a professional sell-side equity research analyst. I currently work for Zacks Investment Research. I started my career with Zacks covering the large-cap Pharma sector in 2003. In 2009, I was promoted to Managing Director of Institutional Equity Research. I now focus on small-cap biotech for Zacks.

Prior to Zacks, I spent 3 years on the buy-side with Eastover Capital in Charlotte, NC where I focused on large-cap equities, specializing in healthcare, energy, and technology.

Prior to joining Eastover, I worked as a research scientist for TechLab, Inc., a biotechnology company focused on developing diagnostic kits and vaccines for infectious diseases. I also spent a year working at the Fralin ...More
  • Description: Sell Side Research Analyst/Trader. Trading frequency: Infrequent
  • Interests: Stocks - long
BioNapCFA Biotech stock articles and consulting. I am available to speak with investors on any article I write or stock I cover. Rates: $100 for 30 min, $200 for 60 min, $500 per month "all-access".
Second Quarter Results Confirm Why We Like Aastrom $ASTM about 16 hours ago